Food and Drug Administration Response to the ATTUD/SRNT Policy Statement on the Labeling of Nicotine Replacement Therapies.
Saved in:
| Title: | Food and Drug Administration Response to the ATTUD/SRNT Policy Statement on the Labeling of Nicotine Replacement Therapies. |
|---|---|
| Authors: | Winchell C; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD., Raffaelli RM; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ryan.raffaelli@fda.hhs.gov., Roca R; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD., Michele T; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD. |
| Source: | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco [Nicotine Tob Res] 2016 May; Vol. 18 (5), pp. 1218-9. Date of Electronic Publication: 2015 Jun 25. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9815751 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-994X (Electronic) Linking ISSN: 14622203 NLM ISO Abbreviation: Nicotine Tob Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1469-994X |
|---|---|
| DOI: | 10.1093/ntr/ntv141 |
